Af­ter promis­ing Trump new US jobs, Eli Lil­ly sets out to chop 200 R&D staffers

Eli Lil­ly is bring­ing out the cor­po­rate ax and aim­ing it at its R&D op­er­a­tions.

Just weeks af­ter the com­pa­ny an­nounced plans to lay off 485 staffers that had been in­volved in the failed solanezum­ab pro­gram, the com­pa­ny spread word on Fri­day that it’s look­ing for 200 re­searchers to take a “vol­un­tary ex­it.”

A spokesper­son for Lil­ly tells me that this amount to about 3% of the com­pa­ny’s to­tal re­search staff. And the cuts aren’t be­ing aimed at any par­tic­u­lar unit.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.